Neurodevelopmental Disorders in Children: Neuroplasticity and Possibilities of Nootropic Pharmacotherapy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Neurodevelopmental Disorders (NDD) are characterized by disturbances of the formation of cognitive functions, communication skills, behavior characteristics and / or motor skills, which are caused by abnormalities in the course of the processes of neuroontogenesis. Factors of the etiology and pathogenesis of NDD include genetic mechanisms, early damage to the developing brain, and adverse external influences. Most forms of NDD manifest themselves in the early stages of development and before the child begins school eduction. The most common NDD, with which medical doctors of various specialties constantly meet, include speech development disorders and attention deficit hyperactivity disorder (ADHD). Since disorders of neuroplasticity processes are considered among the mechanisms of the NDD pathogenesis, their therapy should be aimed at restoring and stimulating the neuroplasticity potential. Manifestations of NDD, undergoing age-related evolution, significantly disrupt normal life and have an adverse effect on various functional areas not only in children, but also in adolescents and adults. The increase in symptoms in patients with NDD at one age or another is not due to the progressive nature of cerebral changes, but to increased difficulties of adaptation with increasing loads, including educational, social, professional ones. Therefore, in most cases, they require many years of complex management and the use of pharmacotherapy, the prospects of which are primarily associated with nootropic drugs. The data of new studies on the effectiveness of nootropics in developmental dysphasia and ADHD are discussed, and possible mechanisms of the nootropics influence on neuroplasticity processes are considered.

About the authors

N. N. Zavadenko

Pirogov Russian National Research Medical University

Email: nchjournal@gmail.com
Russia, Moscow

References

  1. Boivin M.J., Kakooza A.M., Warf B.C., Davidson L.L., Grigorenko E.L. // Nature. 2015. V. 527 (7578). S. 155–160. https://doi.org/10.1038/nature16029
  2. World Health Organization. International statistical classification of diseases and related health problems (11th ed.). 2019. https://icd.who.int/.
  3. Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V) / Arlington, VA: American Psychiatric Association, 2013. 947 p.
  4. Morris-Rosendahl D.J., Crocq M.A. // Dialogues Clin. Neurosci. 2020. V. 22(1). P. 65–72. https://doi.org/10.31887/DCNS.2020.22.1/macrocq
  5. Arnett A.B., Wang T., Eichler E.E., Bernier R.A. // J. Neurodevelopmental Disorders. 2021. V. 13(1). № 24. https://doi.org/10.1186/s11689-021-09371-4
  6. Parenti I., Rabaneda L.G., Schoen H., Novarino G. // Trends in Neurosciences. 2020. V. 43(8). P. 608–621. https://doi.org/10.1016/j.tins.2020.05.004
  7. Smith M.R., Glicksberg B.S., Li L., Chen R., Morishita H., Dudley J.T. // Pac. Symp. Biocomput. 2018. V. 23. P. 68–79.
  8. Neville H., Bavelier D. // Prog. Brain Res. 2002. V. 138. P. 177–188. https://doi.org/10.1016/S0079-6123(02)38078-6
  9. Meredith R.M. // Neurosci. Biobehav. Rev. 2015. V. 50. P. 180–188. https://doi.org/10.1016/j.neubiorev.2014.12.001
  10. Rapoport J.L., Gogtay N. // Neuropsychopharmacology. 2008. V. 33(1). P. 181–197. https://doi.org/10.1038/sj.npp.1301553
  11. Заваденко Н.Н., Холин А.А., Заваденко А.Н., Мичурина Е.С. // Журнал неврологии и психиатрии им. С.С. Корсакова. 2018. Т. 118. № 8. С. 118–125. https://doi.org/10.17116/jnevro2018118081118
  12. Collisson B.A., Graham S.A., Preston J.L., Sarah Rose M., McDonald S., Tough S. // J. Pediatr. 2016. V. 172. P. 168–174. e1. https://doi.org/10.1016/j.jpeds.2016.02.020
  13. Vogel J.P., Chawanpaiboon S., Moller A.B., Watananirun K., Bonet M., Lumbiganon P. // Best Pract. Res. Clin. Obstet. Gynaecol. 2018. V. 52. P. 3–12. https://doi.org/10.1016/j.bpobgyn.2018.04.003
  14. Sansavini A., Guarini A., Justice L.M., Savini S., Broccoli S., Alessandroni R., Faldella G. Early Human Dev. 2010. V. 86. № 12. P. 765–772. https://doi.org/10.1016/j.earlhumdev.2010.08.014
  15. Barre N., Morgan A., Doyle L.W., Anderson P.J. // The Journal of Pediatrics. 2011. V. 158. № 5. P. 766–774. e1. https://doi.org/10.1016/j.jpeds.2010.10.032
  16. Ismail F.Y., Fatemi A., Johnston M.V. // Eur. J. Paediatr. Neurol. 2017. V. 21. № 1. P. 23–48. https://doi.org/10.1016/j.ejpn.2016.07.007
  17. Боголепова А.Н., Чуканова Е.И. // Журн. неврологии и психиатрии им. C.C. Корсакова. 2010. Т. 110. № 8. С. 62–65.
  18. Tsai S.J. // Cytokine Growth Factor Rev. 2017. V. 34. P. 35–41. https://doi.org/10.1016/j.cytogfr.2016.11.003
  19. Bilgiç A., Ferahkaya H., Kilinç İ., Energin V.M. // Noro Psikiyatr Ars. 2021. V. 58. № 2. P. 128–132. https://doi.org/10.29399/npa.27274
  20. Kurkin D.V., Bakulin D.A., Morkovin E.I., Kalatanova A.V., Makarenko I.E., Dorotenko A.R., Kovalev N.S., Dubrovina M.A., Verkholyak D.V., Abrosimova E.E., Smir-nov A.V., Shmidt M.V., Tyurenkov I.N. PLoS One. 2021. V. 16. № 7. e0254493. https://doi.org/10.1371/journal.pone.0254493
  21. Law J., Dennis J.A., Charlton J.J.V. // Cochrane Database of Systematic Reviews. 2017. Issue 1. Art. № CD012490.
  22. Заваденко Н.Н., Давыдова Л.А., Суворинова Н.Ю. // Журнал неврологии и психиатрии им. С.С. Корсакова. 2020. Т. 120. № 10. С. 38–44. https://doi.org/10.17116/jnevro202012010138
  23. Гомазков О.А. // Журнал неврологии и психиатрии им. С.С. Корсакова. 2015. Т. 115. № 8. С. 99–104. https://doi.org/10.17116/jnevro20151158199-104
  24. Гуляева Н.В. // Журнал неврологии и психиатрии им. С.С. Корсакова. 2018. Т. 118. № 10. С. 93–96. https://doi.org/10.17116/jnevro201811810193
  25. Яковлев А.А., Гуляева Н.В. // Нейрохимия. 2017. Т. 34. № 1. С. 91–96. https://doi.org/10.7868/S1027813316040166
  26. Демченко А.В., Беленичев И.Ф. // Нейрохимия. 2016. Т. 10. № 1. С. 64–68. https://doi.org/10.7868/S1027813316010052
  27. Чутко Л.С., Сурушкина С.Ю. // Журнал неврологии и психиатрии им. С.С. Корсакова. 2020. Т. 120. № 2. С. 120–124. https://doi.org/10.17116/jnevro2020120021120
  28. Заваденко Н.Н. // Гиперактивность и дефицит внимания в детском возрасте. 2-е изд., перераб. и доп. М.: Юрайт, 2019, 274 с.
  29. Wolraich M.L., Hagan J.F., Allan C., Chan E., Davison D., Earls M., Evans S.W., Flinn S.K., Froehlich T., Frost J., Holbrook J.R., Lehmann C.U., Lessin H.R., Okechukwu K., Pierce K.L., Winner J.D., Zurhellen W. // Pediatrics. 2019. V. 144. № 4. e20192528. https://doi.org/10.1542/peds.2019-2528
  30. Banaschewski T., Becker K., Döpfner M., Holtmann M., Rösler M., Romanos M. // Dtsch. Ärztebl. Int. 2017. V. 114. P. 149–159. https://doi.org/10.3238/arztebl.2017.0149
  31. Demontis D., Walters R.K., Martin J. et al. // Nat. Genet. 2019. V. 51. P. 63–75. https://doi.org/10.1038/s41588-018-0269-7
  32. Joseph N., Zhang-James Y., Perl A., Faraone S.V. // J. Atten. Disord. 2015. V. 19. № 11. P. 915–924. https://doi.org/10.1177/1087054713510354
  33. Nasim S., Naeini A.A., Najafi M., Ghazvini M., Hassanzadeh A. // Int J Prev Med. 2019. V. 10. P. 41. https://doi.org/10.4103/ijpvm.IJPVM_80_18
  34. Corona J.C. // Antioxidants (Basel). 2020. V. 9. № 11. 1039. https://doi.org/10.3390/antiox9111039
  35. Alvarez-Arellano L., González-García N., Salazar-García M., Corona J.C. // Antioxidants (Basel). 2020. V. 9. № 2. 176. https://doi.org/10.3390/antiox9020176
  36. Curpan A.S., Luca A.C., Ciobica A. // Oxid. Med. Cell. Longev. 2021. P. 6640206. https://doi.org/10.1155/2021/6640206
  37. Щулькин А.В. // Журнал неврологии и психиатрии им. С.С. Корсакова. 2018. Т. 118. № 12. Вып. 2. С. 87–93. https://doi.org/10.17116/jnevro201811812287
  38. Заваденко Н.Н., Суворинова Н.Ю., Батышева Т.Т., Быкова О.В., Платонова А.Н., Гайнетдинова Д.Д., Левитина Е.В., Машин В.В., Вакула И.Н., Максимова Н.Е. // Журнал неврологии и психиатрии им. С.С. Корсакова. 2022. Т. 22. № 4. С. 75–86. https://doi.org/10.17116/jnevro202212204175
  39. Заваденко Н.Н., Суворинова Н.Ю., Вакула И.Н., Малинина Е.В., Кузенкова Л.М. // Журнал неврологии и психиатрии им. С.С. Корсакова. 2017. Т. 117. № 5. С. 39–45. https://doi.org/10.17116/jnevro20171175139-45
  40. Ковалёв Г.И., Сухорукова Н.А., Васильева Е.В., Кондрахин Е.А., Салимов Р.М. // Биомедицинская химия. 2021. Т. 67. Вып. 5. С. 402–410. https://doi.org/10.18097/PBMC20216705402
  41. Заваденко Н.Н., Макушкин Е.В., Гайнетдинова Д.Д., Колоколов О.В., Малинина Е.В., Антипенко Е.А., Сагутдинова Э.Ш., Халецкая О.В., Дмитриев А.В., Маслова Н.Н., Машин В.В., Пантелеева М.В. // Журнал неврологии и психиатрии им. С.С. Корсакова. 2022. Т. 22. № 11. С. 62–68. https://doi.org/10.17116/jnevro202212211162
  42. Tarasov S.A., Gorbunov E.A., Don E.S., Emelyanova A.G., Kovalchuk A.L., Yanamala N., Schleker A.S.S., Klein-Seetharaman J., Groenestein R., Tafani J.P., van der Meide P., Epstein O.I. // The Journal of Immunology. 2020. V. 205. № 5. P. 1345–1354. https://doi.org/10.4049/jimmunol.2000098
  43. Woods K.N. // Scientific Reports. 2021. V. 1. № 1. P. 13774. https://doi.org/10.1038/s41598-021-93326-1
  44. Khacheva K.K., Khakimova G.R., Glazunov A.B., Fateeva V.V. / In Kalinin V.V., Hocaoglu C., Mohamed S. (Eds.), Anxiety Disorders – The New Achievements // IntechOpen. 2021. https://doi.org/10.5772/intechopen.92207
  45. Keller T.A., Just M.A. // Neuroimage. 2016. V. 125. P. 256–266. https://doi.org/10.1016/j.neuroimage.2015.10.015
  46. Vértes P., Bullmore E. // Journal of Child Psychology & Psychiatry. 2015. V. 56. № 3. P. 299–320. https://doi.org/10.1111/jcpp.12365

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Н.Н. Заваденко